Dyadic InternationalDYAI
Market Cap: $34.9M
About: Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
Employees: 7
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
50% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 6
18% more funds holding
Funds holding: 33 [Q1] → 39 (+6) [Q2]
0.34% more ownership
Funds ownership: 15.68% [Q1] → 16.02% (+0.34%) [Q2]
8% less capital invested
Capital invested by funds: $7.54M [Q1] → $6.93M (-$611K) [Q2]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
HC Wainwright & Co. Vernon Bernardino 63% 1-year accuracy 5 / 8 met price target | 406%upside $6 | Buy Reiterated | 8 Jul 2024 |